SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-023406
Filing Date
2021-09-22
Accepted
2021-09-22 17:34:59
Documents
1
Period of Report
2021-09-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5819
  Complete submission text file 0001493152-21-023406.txt   7487
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1330 AVENUE OF THE AMERICAS 33RD FLOOR NEW YORK NY 10019
Business Address
O'Malley Brendan M. (Reporting) CIK: 0001884342 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 211270391